Nestlé S.A. (NESN.SW)
Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
At close: 05:31PM CEST
| Previous Close | 96.62 |
| Open | 96.70 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 95.18 - 96.80 |
| 52 Week Range | 89.52 - 112.92 |
| Volume | |
| Avg. Volume | 4,167,481 |
| Market Cap | 249.686B |
| Beta (5Y Monthly) | 0.29 |
| PE Ratio (TTM) | 22.53 |
| EPS (TTM) | 4.23 |
| Earnings Date | Jul 25, 2024 |
| Forward Dividend & Yield | 3.00 (3.10%) |
| Ex-Dividend Date | Apr 22, 2024 |
| 1y Target Est | 108.68 |
Barrons.comNestlé and Other Food Makers Cater to Wegovy, Ozempic Users
Weight loss drugs are rising in popularity, and food companies are cooking up new ways to win over those consumers.
FortuneNestlé’s new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs
The company says its Vital Pursuit line, priced under $5, is high in protein and vitamins, addressing nutrient deficiencies that Ozempic and Wegovy users may have.
The TelegraphNestlé reformulates its food for Ozempic and Wegovy users
Nestlé is launching a new range of protein-enriched pastas and pizzas for people taking weight-loss drugs, amid fears treatments like Wegovy will hammer sales.
© 2024 Yahoo. All rights reserved.